ACG METALS LIMITED:Approval of DTC Eligibility to Improve U.S. Trading Liquidity
DTC is a subsidiary of the Depository Trust & Clearing Corporation and provides the primary electronic clearing and settlement infrastructure used by
The approval of DTC eligibility makes it easier for U.S. investors and broker‑dealers to trade and settle the Company's shares across a broader range of
The Shares also remain eligible for clearing and settlement through the CREST system in the
Inside information
The information contained within this announcement is considered by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No.596/2014 (as it forms part of
The person responsible for the release of this information on behalf of the Company is
For further information please contact:
Thirty Three Communications
Communications Advisor
[email protected]
Berenberg
Research Analysts
+44 (0) 20 3753 3070
Joint Broker
+44 (0) 20 3207 7800
Canaccord
Research Analysts
Joint Broker
+ 44 (0) 20 7523 4680
Stifel
Research Analysts
Joint Broker
+44 (0) 20 7710 7600
Cantor Fitzgerald
Research Analysts
About the Company
ACG Metals is a company with a vision to build a global, high-margin, copper-focused producer with safe, efficient, and sustainable operations.
In
ACG's team has extensive M&A experience built through decades spent at blue-chip multinationals in the sector. The team brings a significant network as well as a commitment to ESG principles and strong corporate governance.
LON: ACG | OTCQX: ACGAF | LON:ACGW | Xetra: ACG | Bond ISIN: NO0013414565
For more information about ACG, please visit: www.acgmetals.com
View original content:https://www.prnewswire.com/news-releases/acg-metals-limited-approval-of-dtc-eligibility-to-improve-us-trading-liquidity-302771592.html
SOURCE ACG METALS LIMITED
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
- 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
- Tahj Mills Announces the Release of Chef: You Should Know I Understand and Companion Album Quick Spoke
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Stifel, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share